US Broker Ratings

PureTech Health plc (PRTC) Stock Analysis: Navigating Challenges in the Biotech Landscape

PureTech Health plc (NASDAQ: PRTC) is a dynamic player in the biotechnology sector, focusing on innovative solutions to tackle complex health issues. Based in the United States, this Boston-incorporated company..

Sana Biotechnology, Inc. (SANA) Stock Analysis: Exploring a Potential 163% Upside with Strategic Innovations

Sana Biotechnology, Inc. (NASDAQ: SANA) is garnering attention in the biotechnology sector with its innovative approach to engineered cell therapies and a significant potential upside of 163.74% based on analyst..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Robust Revenue Growth Amidst Challenges

Sonida Senior Living, Inc. (NASDAQ: SNDA) has been a focal point for investors in the healthcare sector, particularly those interested in the medical care facilities industry. With a market capitalization..

AbCellera Biologics Inc. (ABCL) Stock Analysis: Unveiling an 84.53% Potential Upside for Investors

AbCellera Biologics Inc. (NASDAQ: ABCL), headquartered in Vancouver, Canada, is making waves in the biotechnology industry with its innovative approach to antibody-based medicine discovery and development. As the healthcare sector..

Ginkgo Bioworks Holdings, Inc. (DNA): Investor Outlook Amidst Challenging Metrics and Growth Potential

Ginkgo Bioworks Holdings, Inc. (DNA), a biotechnology company specializing in cell engineering and biosecurity, is navigating a complex landscape marked by both challenges and opportunities. Headquartered in Boston, Massachusetts, Ginkgo..

Organogenesis Holdings Inc. (ORGO) Stock Analysis: Unpacking a 22% Potential Upside in the Healthcare Sector

Organogenesis Holdings Inc. (NASDAQ: ORGO), a prominent player in the healthcare sector focusing on regenerative medicine, offers a compelling opportunity for investors with a potential upside of 22.45%. Despite recent..

Beta Bionics, Inc. (BBNX) Investor Outlook: A 40.73% Potential Upside in the Medical Device Sector

For investors seeking exposure in the healthcare sector, particularly in medical devices, Beta Bionics, Inc. (NASDAQ: BBNX) presents an intriguing opportunity. With its market cap at a robust $642 million,..

Altimmune, Inc. (ALT) Stock Analysis: A Biotech Bet with 477.93% Potential Upside

Altimmune, Inc. (NASDAQ: ALT), a prominent player in the biotechnology sector, is capturing investor attention with its high upside potential and compelling analyst ratings. Headquartered in Gaithersburg, Maryland, Altimmune is..

Cogent Biosciences (COGT) Stock Analysis: A Biotech with Promising Upside and Analyst Confidence

Cogent Biosciences, Inc. (NASDAQ: COGT) is capturing investor attention in the biotechnology sector with a strong market presence and compelling growth potential. As a clinical-stage biotech firm, Cogent is focused..

Zenas BioPharma, Inc. (ZBIO)

⚠️ No article content returned.

..

Tectonic Therapeutic, Inc. (TECX) Stock Analysis: Unpacking a Potential 175% Upside with Strong Buy Ratings

Investors with an eye on the biotechnology sector may find Tectonic Therapeutic, Inc. (TECX) an intriguing opportunity, given its current market dynamics and potential upside. Headquartered in Watertown, Massachusetts, Tectonic..

SIGA Technologies Inc. (SIGA) Stock Analysis: Exploring Growth Potential Amidst Market Volatility

SIGA Technologies Inc. (NASDAQ: SIGA), a key player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, offers a unique proposition for investors interested in the..

Community Health Systems, Inc. (CYH) Stock Analysis: Potential Upside of 14.75% Amidst Challenging Metrics

Community Health Systems, Inc. (NYSE: CYH), a key player in the U.S. healthcare sector, operates a network of general acute care hospitals. Based in Franklin, Tennessee, the company provides a..

AxoGen, Inc. (AXGN) Stock Analysis: Examining a 28.71% Potential Upside in the Medical Device Sector

AxoGen, Inc. (Nasdaq: AXGN) has emerged as a noteworthy player in the healthcare sector, specifically within the medical devices industry. Headquartered in Alachua, Florida, the company specializes in the development..

Neuropace, Inc. (NPCE) Stock Analysis: Healthcare Innovator with 47% Potential Upside

Neuropace, Inc. (NPCE), a niche player in the healthcare sector, specifically within the medical devices industry, has captured the attention of investors with its innovative approach to managing drug-resistant focal..

Maravai LifeSciences Holdings (MRVI) Stock Analysis: Navigating Challenges with a 40.5% Revenue Growth Yet Facing Market Skepticism

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) stands as a prominent player in the biotechnology industry, specializing in the development of critical products for drug therapies, vaccines, and diagnostics. With its..

Relay Therapeutics, Inc. (RLAY) Stock Analysis: A 34% Potential Upside with Strong Buy Ratings

Relay Therapeutics, Inc. (RLAY), a promising player in the biotechnology sector, has caught the attention of investors with its innovative approach to drug discovery and a compelling stock outlook. With..

Fortrea Holdings Inc. (FTRE) Stock Analysis: Navigating the Biotech Sector with 4.49% Upside Potential

For investors keeping a close eye on the healthcare sector, Fortrea Holdings Inc. (NASDAQ: FTRE) presents an intriguing opportunity. With a market capitalization of $1.81 billion, Fortrea operates within the..

COMPASS Pathways Plc (CMPS) Stock Analysis: A Biotech Bet with 105% Potential Upside

COMPASS Pathways Plc (NASDAQ: CMPS), a trailblazer in the mental health sector, is capturing investor attention with a substantial potential upside of 105.27%. As the company progresses in its innovative..

Immunome, Inc. (IMNM) Stock Report: Analyst Consensus Suggests a 54.98% Upside Potential

Immunome, Inc. (NASDAQ: IMNM) is capturing the attention of investors with its promising pipeline in the biotechnology sector. As a company focused on developing innovative oncology therapeutics, Immunome’s current market..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds